AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $24.06M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| SNS | Investor Presentation - Techknow Conference 2018 | 10/04/18 | ||
| SNS | SenSen Secures $0.9 Million Calgary Contract Expansion | PRICE SENSITIVE | 28/03/18 | |
| SNS | SenSen Launches in US with Silicon Harlem Teaming Agreement | PRICE SENSITIVE | 21/03/18 | |
| SNS | Cities 4.0 Summit Presentation | 20/03/18 | ||
| SNS | Appendix 4D and Half-Year Report | PRICE SENSITIVE | 28/02/18 | |
| SNS | SenSen Investor Presentation February 2018 | 26/02/18 | ||
| SNS Investor Presentation - Techknow Conference 2018 | |||
| 10/04/18 | |||
| SNS SenSen Secures $0.9 Million Calgary Contract Expansion | |||
| 28/03/18 | PRICE SENSITIVE | ||
| SNS SenSen Launches in US with Silicon Harlem Teaming Agreement | |||
| 21/03/18 | PRICE SENSITIVE | ||
| SNS Cities 4.0 Summit Presentation | |||
| 20/03/18 | |||
| SNS Appendix 4D and Half-Year Report | |||
| 28/02/18 | PRICE SENSITIVE | ||
| SNS SenSen Investor Presentation February 2018 | |||
| 26/02/18 | |||
